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Nosocomial bloodstream infections are a leading cause of death in the United States. If we assume a
nosocomial infection rate of 5%, of which 10% are bloodstream infections, and an attributable mortality rate
of 15%, bloodstream infections would represent the eighth leading cause of death in the United States.
Because most risk factors for dying after bacteremia or fungemia may not be changeable, prevention efforts
must focus on new infection-control technology and techniques.
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Vital statistics outlining the major causes of death in a
population are an important measure of public health.
Ranking disease agents according to the number of deaths
they cause can be used for strategic planning and public
health resource allocation. In the United States, vital
statistics support efforts to control coronary artery disease,
cancer, cerebrovascular diseases, and infections (Table 1) (1).
A listing of causes of death, however, provides little insight on
how the diseases were acquired or managed or how they
might have been prevented. Infections acquired in the
hospital are an important cause of death, especially those
involving the bloodstream or lung (2).
If hospital infection and death occur at high rates, we can
examine the process of institutional care: access to infection
control personnel, systems for prevention and early
recognition, and early and appropriate therapy. With
improved care, improved outcome could be anticipated. We
explore the impact of hospital-acquired infections, with a
focus on bloodstream infections.
Baseline Data
Population-based surveillance studies of nosocomial
infections in U.S. hospitals indicate a 5% attack rate or
incidence of 5 infections per 1,000 patient-days (3-5). With the
advent of managed care and incentives for outpatient care,
hospitals have a concentrated population of seriously ill
patients, so rates of nosocomial infections are probably
correspondingly higher (6). For many larger institutions, the
nosocomial infection rate may be closer to 10%.
If 35 million patients are admitted each year to the
approximately 7,000 acute-care institutions in the United
States, the number of nosocomial infections—assuming
overall attack rates of 2.5%, 5%, or 10%—would be 875,000,
1.75 million, or 3.5 million, respectively. If 10% of all hospital-
acquired infections involve the bloodstream, 87,500, 175,000,
or 350,000 patients acquire these life-threatening infections
each year.
Crude and Attributable Mortality Rates
The overall or crude rate of death does not distinguish the
contribution of the patients’ underlying diseases from the
contribution of bloodstream infections. Recent data from
the Surveillance and Control of Pathogens of Epidemiologic
Importance [SCOPE] surveillance system of nosocomial
bloodstream infections in U.S. hospitals identified a crude
mortality rate of 27% (7), with great variation by pathogen
(Figure 1).
The direct contribution of nosocomial infection, after the
contribution of the underlying illnesses is accounted for, is the
attributable mortality rate (8). For example, if a crude
mortality rate for nosocomial candidemia of 40% is assumed
(as in the SCOPE surveillance system [7]) and three-eighths
of the deaths are directly due to the underlying diseases (15%
of the 40%), the mortality rate attributable to candidemia
would be 25% (40%-15%). Thus, candidemia would contribute
five-eighths (25% of the 40%) of the crude mortality rate.
Table 1. Deaths and death rates in the United States, 1997 (1)
  Crude
No. of   death
deaths    rate % of all
Cause of death (x 103) (per 105)  deaths
Heart disease 725.8 271.2 31.4
Malignancies 537.4 200.8 23.2
Cerebrovascular disease 159.9   59.7   6.9
Pneumonia and influenza   88.4   33.0   3.8
Septicemia   22.6     8.4   0.97
Figure 1. Variation in mortality rate by organism causing nosocomial
bloodstream infection (7). The leading four organisms and crude
mortality rate are illustrated.175 Vol. 7, No. 2, March–April 2001 Emerging Infectious Diseases
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Number of Deaths from Nosocomial Infections
Several assumptions may be examined simultaneously
regarding the attack rate and both crude and attributable
mortality rate estimates (Figure 2). By doing so, deaths
directly attributable to nosocomial bloodstream infections
can be calculated, with a range of very conservative to more
liberal estimates based on available data. For example, with
a hospital infection rate of 5%, of which 10% are bloodstream
infections, and an attributable mortality rate of 15%, 26,250
deaths can be directly linked to nosocomial bloodstream
infections. However, if a 20% attributable  mortality rate is
assumed, the number of deaths is from 17,500 (with a 2.5%
nosocomial infection rate) to 70,000 (with a 10% total
nosocomial infection rate).
With various assumptions about total nosocomial
infection rates and attributable mortality rate, the ranking of
nosocomial bloodstream infections among leading causes of
death can be estimated (Figure 3). This ranking reflects the
total number of deaths compared with the reported numbers
of leading causes of death in the United States (1). From the
above estimates, if nosocomial bloodstream infections alone
were counted, they would represent the fourth to thirteenth
cause of death in the United States.
The impact of nosocomial bloodstream infections can also
be examined in terms of years of life lost. SCOPE (M. Edmond,
pers. comm.) indicates that the median age of patients dying
of nosocomial bloodstream infections is 57 years. If these
patients are 60 years of age, without bloodstream infection
they would have lived to age 70. This assumption is
reasonable since only attributable deaths are included in the
calculations (Figure 4). As an example, if the attributable
mortality rate is 20% and the total nosocomial infection rate
is 5%, the total number of years of life lost in the United States
would be 350,000 annually. If the attributable mortality rate
were only 10%, the number of years of life lost annually would
be 87,500 to 350,000, depending on the total infection rate.
Conclusions
The arguments above justify a major effort with
substantial resources for preventing and controlling serious
hospital-acquired infections. We suggest a quality assess-
ment approach for hospital-based programs of infection
control: structure, process, and outcome. The Study of the
Efficacy of Nosocomial Infection Control (SENIC), published
in 1985, showed that both structure (expertise) and process
(surveillance, feedback and protocols) predicted lower
infection rates (9). A subsequent analysis suggested that
infection control programs represented one of the most cost
effective of current public health efforts (10).
Access to improved infection-control technology is one of
the promises at the dawn of the 21st century. Another is
Figure 2. Estimated num-
ber of deaths caused by
nosocomial  infections in
the United States each
year. Attributable mor-
tality rates are 10% to
30% on the X axis, and
the three curves assume
overall nosocomial infec-
tion rates of 2½%, 5%, or
10%.
Figure 3. Leading causes of death are ranked according to
attributable mortality rate and compared with number of deaths
from leading causes in the United States (1).176 Emerging Infectious Diseases Vol. 7, No. 2, March–April 2001
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improved handwashing compliance associated with more
attractive and accessible products. Two recent factors
influencing infection control are use of antibiotic-bonded
vascular catheters and access to alcohol hand-cleansing
materials that improve handwashing compliance. In a
multicenter study reported by Darouiche and colleagues,
bloodstream infections were significantly reduced when
patients received catheters bonded with rifampin and
minocycline (11). Estimates of nosocomial bloodstream
infections from the SCOPE database indicate that 70% occur
in patients with central venous catheters (12). Furthermore,
the study by Darouiche et al. showed that 90% of central
venous catheter-associated infections could be prevented by
antibiotic-bonded catheters. Assuming 200,000 total nosoco-
mial bloodstream infections of which 35% are attributable to
central venous catheters and assuming that 45% could be
prevented with a catheter bonded with minocycline and
rifampin, the number of lives saved according to varying
attributable mortality rate estimates would be 4,745 to 9,450
(Table 2).
In a study of handwashing compliance by Bishoff and
colleagues, handwashing frequency in a medical intensive-
care unit (ICU) increased with access to an alcohol-based
product (13). Previously, Doebbeling and colleagues showed
that medicated soap solutions were more popular than alcohol
preparations and thus were associated with reduced infection
in intensive care units (14). The study by Doebbeling et al.
showed that a 28% increase in handwashing frequency (with
a higher volume of use of antiseptic soap) resulted in a
substantial reduction in the rate of nosocomial bloodstream
infections of 56/10,000 ICU admissions, by 45% for the attack
rate and by 22% when incidence density was calculated (Table
3). In SCOPE, 49.4% of all nosocomial bloodstream infections
occurred in intensive-care units. However, if 25%-50% of all
Figure 4. Years of life
lost annually in the
United States from
nosocomial  infec-
tions. Attributable
mortality rates are
10% to 30% on the X
axis, and the three
curves assume over-
all nosocomial infec-
tion rates of 2½%,
5%, or 10%.
Table 2. Central venous catheter technology and nosocomial bloodstream infections and deaths
Attributable Expected CVCa-related deaths  No. of deaths remaining  if new
mortality rate (%) from bloodstream infectionsb catheters prevent 45% of deaths No. of lives saved
15 10,500   5,755 4,745
20 14,000   7,700 6,300
25 17,500   9,625 7,875
30 21,000 11,550 9,450
aCVC = Central venous catheter.
bAssumptions in this analysis: 200,000 bloodstream infections/year, 35% attributed to CVCs, 45% prevented with antibiotic-bonded catheters.
Previous studies showed 175,000-350,000 nosocomial bloodstream infections/year, 70% of which were related to central venous catheters; 90%
of central venous catheter-related bloodstream infections prevented with antibiotic bonded catheters (11).
Table 3. Handwashing and nosocomial bloodstream infections and deaths
Attributable No. of lives saves if 25% No. of lives saved if 50%
mortality rate (%) Expected deaths  of BSIa occur in ICUsb    of BSI occur in ICUs
15 1,875 469    938
20 2,500 625 1,250
25 3,125 781 1,562
30 3,750 937 1,874
aBSI = Bloodstream infections; ICU = Intensive-care unit.
bAssumptions in this analysis: 50,000 (25%) or 100,000 (50%) of BSI occur in ICUs, and a 25% increase in handwashing prevented 25% of BSIs.
Known (14): In ICUs, a 28% increase in handwashing was related to a reduction of risk of BS1 of 56/10,000 ICU admissions, a reduced attack
rate of 45%, and a reduced incidence density rate of 22%.177 Vol. 7, No. 2, March–April 2001 Emerging Infectious Diseases
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bloodstream infections occur in intensive-care units and a
25% increase in handwashing would prevent 25% of
bloodstream infections in ICUs, the number of lives saved
would be 469 to 1,874, depending on assumptions of
attributable death rate (Table 3). The emerging concept is
that increased handwashing frequency will result in an
improved outcome. Perhaps most striking is that in this
selected comparison of the impact of changes in technology
with changes in behavior, the former will likely be 5 to 10
times more effective, but at substantially increased cost.
Neither, however, is mutually exclusive, and both need to be
in place.
In summary, vital statistics list the major causes of death
yet give little insight into environmental risk factors for
disease or outcomes. Estimates of hospital-acquired
bloodstream infections derived from the attributable
mortality rate show the impact of the specific environment
where many life-threatening infections occur. By modifying
the institutional environment to improve hospital care and
infection control, the outcomes for patients will greatly
improve. Technological advances will likely have a greater
impact on health than theoretical advances in behavior, such
as improved handwashing frequency.
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